<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Schimunek J</submitter><funding>AXA Research Fund</funding><funding>NIGMS NIH HHS</funding><pagination>e202300262</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC11299051</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>43(1)</volume><pubmed_abstract>The COVID-19 pandemic continues to pose a substantial threat to human lives and is likely to do so for years to come. Despite the availability of vaccines, searching for efficient small-molecule drugs that are widely available, including in low- and middle-income countries, is an ongoing challenge. In this work, we report the results of an open science community effort, the "Billion molecules against COVID-19 challenge", to identify small-molecule inhibitors against SARS-CoV-2 or relevant human receptors. Participating teams used a wide variety of computational methods to screen a minimum of 1 billion virtual molecules against 6 protein targets. Overall, 31 teams participated, and they suggested a total of 639,024 molecules, which were subsequently ranked to find 'consensus compounds'. The</pubmed_abstract><journal>Molecular informatics</journal><pubmed_title>A community effort in SARS-CoV-2 drug discovery.</pubmed_title><pmcid>PMC11299051</pmcid><funding_grant_id>R35 GM130587</funding_grant_id><pubmed_authors>Gianquinto E</pubmed_authors><pubmed_authors>Musiani F</pubmed_authors><pubmed_authors>Elez K</pubmed_authors><pubmed_authors>Gokcan H</pubmed_authors><pubmed_authors>Steinkellner G</pubmed_authors><pubmed_authors>Furs KV</pubmed_authors><pubmed_authors>Mukherjee G</pubmed_authors><pubmed_authors>Wheeler TJ</pubmed_authors><pubmed_authors>Casini A</pubmed_authors><pubmed_authors>Tsengenes A</pubmed_authors><pubmed_authors>White KM</pubmed_authors><pubmed_authors>Copeland C</pubmed_authors><pubmed_authors>Hempel T</pubmed_authors><pubmed_authors>Venkatraman V</pubmed_authors><pubmed_authors>Schimunek J</pubmed_authors><pubmed_authors>Hochreiter S</pubmed_authors><pubmed_authors>Druzhilovskiy DS</pubmed_authors><pubmed_authors>Theodorakis S</pubmed_authors><pubmed_authors>Lombino J</pubmed_authors><pubmed_authors>Walsh MA</pubmed_authors><pubmed_authors>Olson DR</pubmed_authors><pubmed_authors>Widrich M</pubmed_authors><pubmed_authors>Gusev F</pubmed_authors><pubmed_authors>Maliutin A</pubmed_authors><pubmed_authors>Barnsley K</pubmed_authors><pubmed_authors>De Rosa M</pubmed_authors><pubmed_authors>Charton B</pubmed_authors><pubmed_authors>Filimonov DA</pubmed_authors><pubmed_authors>Gruber K</pubmed_authors><pubmed_authors>Garcia-Sastre A</pubmed_authors><pubmed_authors>Voigt CA</pubmed_authors><pubmed_authors>Zettor A</pubmed_authors><pubmed_authors>Naffakh N</pubmed_authors><pubmed_authors>Bosko IP</pubmed_authors><pubmed_authors>Gil G</pubmed_authors><pubmed_authors>Wang ZF</pubmed_authors><pubmed_authors>Talarico C</pubmed_authors><pubmed_authors>Falsafi B</pubmed_authors><pubmed_authors>Lei D</pubmed_authors><pubmed_authors>Krischuns T</pubmed_authors><pubmed_authors>Medvedev A</pubmed_authors><pubmed_authors>Bengio Y</pubmed_authors><pubmed_authors>Kurnikova MG</pubmed_authors><pubmed_authors>Goßen J</pubmed_authors><pubmed_authors>Gorgulla C</pubmed_authors><pubmed_authors>Padmanabha Das KM</pubmed_authors><pubmed_authors>Perricone U</pubmed_authors><pubmed_authors>Bengio E</pubmed_authors><pubmed_authors>Schroeder M</pubmed_authors><pubmed_authors>De Simone G</pubmed_authors><pubmed_authors>Kaiser F</pubmed_authors><pubmed_authors>Beccari A</pubmed_authors><pubmed_authors>Manelfi C</pubmed_authors><pubmed_authors>Gutkin EM</pubmed_authors><pubmed_authors>Mayr A</pubmed_authors><pubmed_authors>Gaiser J</pubmed_authors><pubmed_authors>Gruber C</pubmed_authors><pubmed_authors>Durmaz V</pubmed_authors><pubmed_authors>Pandita S</pubmed_authors><pubmed_authors>Athanasiou C</pubmed_authors><pubmed_authors>Roy A</pubmed_authors><pubmed_authors>Singh A</pubmed_authors><pubmed_authors>Gulotta MR</pubmed_authors><pubmed_authors>Raich L</pubmed_authors><pubmed_authors>Gordon DB</pubmed_authors><pubmed_authors>Hanke A</pubmed_authors><pubmed_authors>Rodriguez ML</pubmed_authors><pubmed_authors>Zhang KYJ</pubmed_authors><pubmed_authors>Spyrakis F</pubmed_authors><pubmed_authors>Fischer PD</pubmed_authors><pubmed_authors>Pugliese L</pubmed_authors><pubmed_authors>Jacob Y</pubmed_authors><pubmed_authors>Sadiq SK</pubmed_authors><pubmed_authors>Cespugli M</pubmed_authors><pubmed_authors>Eghbal-Zadeh H</pubmed_authors><pubmed_authors>Iyengar SM</pubmed_authors><pubmed_authors>Watowich S</pubmed_authors><pubmed_authors>Paiardi G</pubmed_authors><pubmed_authors>Olsson S</pubmed_authors><pubmed_authors>Jain MJ</pubmed_authors><pubmed_authors>Benabderrahmane MB</pubmed_authors><pubmed_authors>Arthanari H</pubmed_authors><pubmed_authors>Klambauer G</pubmed_authors><pubmed_authors>Muniz-Chicharro A</pubmed_authors><pubmed_authors>Krasoulis A</pubmed_authors><pubmed_authors>Epitropakis N</pubmed_authors><pubmed_authors>Brooks CL</pubmed_authors><pubmed_authors>Allen WJ</pubmed_authors><pubmed_authors>Antonopoulos N</pubmed_authors><pubmed_authors>D'Arrigo G</pubmed_authors><pubmed_authors>Seidl P</pubmed_authors><pubmed_authors>Chen KY</pubmed_authors><pubmed_authors>Liu CH</pubmed_authors><pubmed_authors>Yust RJ</pubmed_authors><pubmed_authors>Pratt K</pubmed_authors><pubmed_authors>Isayev O</pubmed_authors><pubmed_authors>Shuldau M</pubmed_authors><pubmed_authors>Wagner G</pubmed_authors><pubmed_authors>Glaab E</pubmed_authors><pubmed_authors>Von Delft F</pubmed_authors><pubmed_authors>Le T</pubmed_authors><pubmed_authors>Varnek A</pubmed_authors><pubmed_authors>Bousquet-Melou P</pubmed_authors><pubmed_authors>Ondrechen MJ</pubmed_authors><pubmed_authors>Pogodin PV</pubmed_authors><pubmed_authors>Veselovsky AV</pubmed_authors><pubmed_authors>Embree A</pubmed_authors><pubmed_authors>Popov P</pubmed_authors><pubmed_authors>Sirimulla S</pubmed_authors><pubmed_authors>Ruch P</pubmed_authors><pubmed_authors>Noe F</pubmed_authors><pubmed_authors>Hermans TM</pubmed_authors><pubmed_authors>Cirou BC</pubmed_authors><pubmed_authors>Berenger F</pubmed_authors><pubmed_authors>Yushkevich A</pubmed_authors><pubmed_authors>Yamanishi Y</pubmed_authors><pubmed_authors>Carloni P</pubmed_authors><pubmed_authors>Halmich C</pubmed_authors><pubmed_authors>Blaschitz K</pubmed_authors><pubmed_authors>Bureau R</pubmed_authors><pubmed_authors>Kornoushenko YV</pubmed_authors><pubmed_authors>Haupt VJ</pubmed_authors><pubmed_authors>Rudik AV</pubmed_authors><pubmed_authors>Hetmann M</pubmed_authors><pubmed_authors>Zaretckii M</pubmed_authors><pubmed_authors>Itsikalis V</pubmed_authors><pubmed_authors>Kovachka S</pubmed_authors><pubmed_authors>Karpenko AD</pubmed_authors><pubmed_authors>Marcou G</pubmed_authors><pubmed_authors>Yup Lee S</pubmed_authors><pubmed_authors>Joseph BP</pubmed_authors><pubmed_authors>Kozlovskii I</pubmed_authors><pubmed_authors>Fackeldey K</pubmed_authors><pubmed_authors>Tesseyre G</pubmed_authors><pubmed_authors>Korablyov M</pubmed_authors><pubmed_authors>Poroikov V</pubmed_authors><pubmed_authors>Stolbov LA</pubmed_authors><pubmed_authors>Albani S</pubmed_authors><pubmed_authors>Winter R</pubmed_authors><pubmed_authors>Mekni N</pubmed_authors><pubmed_authors>Kokh DB</pubmed_authors><pubmed_authors>Rossetti G</pubmed_authors><pubmed_authors>Narangoda CH</pubmed_authors><pubmed_authors>Wade RC</pubmed_authors><pubmed_authors>Kinney JE</pubmed_authors><pubmed_authors>Ford B</pubmed_authors><pubmed_authors>Fearon D</pubmed_authors><pubmed_authors>Zubatyuk R</pubmed_authors><pubmed_authors>Kumar A</pubmed_authors><pubmed_authors>Nunes-Alves A</pubmed_authors><pubmed_authors>Lafaye P</pubmed_authors><pubmed_authors>Horvath D</pubmed_authors></additional><is_claimable>false</is_claimable><name>A community effort in SARS-CoV-2 drug discovery.</name><description>The COVID-19 pandemic continues to pose a substantial threat to human lives and is likely to do so for years to come. Despite the availability of vaccines, searching for efficient small-molecule drugs that are widely available, including in low- and middle-income countries, is an ongoing challenge. In this work, we report the results of an open science community effort, the "Billion molecules against COVID-19 challenge", to identify small-molecule inhibitors against SARS-CoV-2 or relevant human receptors. Participating teams used a wide variety of computational methods to screen a minimum of 1 billion virtual molecules against 6 protein targets. Overall, 31 teams participated, and they suggested a total of 639,024 molecules, which were subsequently ranked to find 'consensus compounds'. The</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Jan</publication><modification>2025-04-05T15:03:08.344Z</modification><creation>2025-02-19T04:40:33.561Z</creation></dates><accession>S-EPMC11299051</accession><cross_references><pubmed>37833243</pubmed><doi>10.1002/minf.202300262</doi></cross_references></HashMap>